Dizziness, often manifesting as vertigo, is a common clinical complaint encountered in medical practice. Despite its prevalence, the condition often poses diagnostic challenges due to its multifactorial etiology. This article aims to provide a comprehensive clinical approach to vertigo, assisting healthcare professionals in its accurate diagnosis and management.
Vertigo is a subtype of dizziness characterized by the sensation of self-motion or environmental movement. It is primarily a symptom of vestibular dysfunction, which can be either peripheral or central. Peripheral causes include benign paroxysmal positional vertigo (BPPV), Meniere's disease, and vestibular neuritis, while central causes encompass cerebrovascular disorders, migraines, and multiple sclerosis.
A thorough history and physical examination are essential for diagnosing vertigo. Key elements to consider include the onset, duration, triggers, associated symptoms, and any history of hearing loss or tinnitus. The Dix-Hallpike maneuver and the head impulse test can help differentiate between peripheral and central causes.
While history and physical examination are often sufficient for diagnosis, additional diagnostic tools may be required in complex cases. These may include audiometry, vestibular function tests, and neuroimaging studies. A multidisciplinary approach involving otolaryngologists, neurologists, and audiologists may be beneficial.
Management of vertigo depends primarily on its underlying cause. BPPV can be managed with canalith repositioning maneuvers, while Meniere's disease may require dietary modifications, diuretics, and possibly surgery. Vestibular rehabilitation therapy is beneficial for most types of vertigo, particularly in patients with chronic symptoms.
Vertigo, while common, can often be a diagnostic conundrum. A systematic approach, combining a meticulous history, physical examination, and judicious use of diagnostic tools, can aid in accurate diagnosis and effective management. As healthcare professionals, our goal should be not only to treat vertigo but also to improve our patients' quality of life.
1.
Mosunetuzumab in Follicular Lymphoma: Durable Responses and Manageable Safety
2.
As EGFR internalization is decreased, BUB1 controls EGFR signaling.
3.
Getting Lung Cancer Screening Staff Involved Improved Tobacco Cessation
4.
Low Income, Education Tied to Depression in Older Adults
5.
In Higher-Risk MDS, CMML, All-Oral Therapy Has Promise.
1.
Bridging Disciplines: Medical Oncology vs Surgical Oncology in the Era of Multidisciplinary Cancer Care
2.
Next-Gen CAR Cell Therapies in Oncology: Frontiers in Solid Tumors & Hematologic Malignancies
3.
Next-Generation Sequencing in Oncology: Unlocking the Future of Precision Medicine
4.
Unlocking the Key to Treating Lymphoma: New Innovations in Cancer Research
5.
Personalizing Cancer Care: Microbiome Advances, Challenges, and Future Directions
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part VI
2.
Targeting Oncologic Drivers: A New Approach to Lung Cancer Treatment
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part IV
4.
Managing CNS diseases at the point of diagnosis in ALK + NSCLC
5.
Navigating the Complexities of Ph Negative ALL - Part XV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation